Display options
Share it on
Full text links
Wiley

Lipids. 1995 Sep;30(9):855-61. doi: 10.1007/BF02533962.

Hydrophilic bile acids: prevention and dissolution experiments in two animal models of cholesterol cholelithiasis.

Lipids

B I Cohen, T Mikami, N Ayyad, A Ohshima, R Infante, E H Mosbach

Affiliations

  1. Department of Surgery, Beth Israel Medical Center, New York, New York 10003, USA.

PMID: 8577230 DOI: 10.1007/BF02533962

Abstract

The effects of beta-muricholic acid and hyocholic acid on cholesterol cholelithiasis were examined in two animal models. The following experiments were carried out: A) In a gallstone prevention study, prairie dogs were fed the lithogenic diet with or without 0.1% beta-muricholic or 0.1% hyocholic acid for eight weeks. B) In a second prevention study, hamsters were fed the lithogenic diet with or without 0.1% beta-muricholic acid or 0.1% hyocholic acid for six weeks. C) In a gallstone dissolution study, hamsters were fed the lithogenic diet for six weeks to induce stones; stone dissolution was examined during administration of a cholesterol-free purified diet with or without 0.1% beta-muricholic acid or 0.1% hyocholic acid. In the prevention study in prairie dogs (A), both bile acids failed to prevent stone formation, the cholesterol saturation index of bile was 0.89 in the lithogenic controls, remained unchanged with hyocholic acid and increased to 1.52 in the beta-muricholic acid group. In the prevention study in hamsters (B), beta-muricholic acid completely inhibited the cholesterol cholelithiasis (0% stone incidence); the cholesterol saturation index of bile was 1.78 (compared to lithogenic controls, 1.37). Hyocholic acid reduced stone incidence to 16% with a cholesterol saturation index of 0.98. In the dissolution study in hamsters (C), preexisting cholesterol gallstones were not dissolved by either hydrophilic bile acid after feeding these bile acids for an additional six weeks; at the end of the experiment, the cholesterol saturation indices were below unity.(ABSTRACT TRUNCATED AT 250 WORDS)

References

  1. J Lipid Res. 1984 Jun;25(6):539-49 - PubMed
  2. Gastroenterology. 1965 Feb;48:261-2 - PubMed
  3. Am J Physiol. 1964 Mar;206:628-34 - PubMed
  4. JAMA. 1993 Feb 24;269(8):1018-24 - PubMed
  5. Gastroenterology. 1982 Oct;83(4):753-60 - PubMed
  6. Steroids. 1985 May;45(5):411-26 - PubMed
  7. Gastroenterol Jpn. 1983 Apr;18(2):93-7 - PubMed
  8. J Lipid Res. 1980 Jan;21(1):35-43 - PubMed
  9. Lipids. 1994 Jul;29(7):503-8 - PubMed
  10. J Lipid Res. 1993 Oct;34(10):1709-16 - PubMed
  11. Gastroenterology. 1990 Feb;98(2):397-405 - PubMed
  12. J Lipid Res. 1990 Jan;31(1):55-70 - PubMed
  13. Hepatology. 1985 Jan-Feb;5(1):102-7 - PubMed
  14. Adv Intern Med. 1988;33:409-30 - PubMed
  15. J Lipid Res. 1983 May;24(5):604-13 - PubMed
  16. Biochim Biophys Acta. 1987 Mar 13;918(1):1-10 - PubMed
  17. JAMA. 1978 Mar 20;239(12):1138-44 - PubMed
  18. Hepatology. 1984 Sep-Oct;4(5 Suppl):199S-208S - PubMed
  19. J Lipid Res. 1986 Apr;27(4):442-6 - PubMed
  20. J Biol Chem. 1957 Apr;225(2):811-23 - PubMed
  21. J Clin Invest. 1976 Jul;58(1):97-108 - PubMed
  22. Lipids. 1986 Sep;21(9):575-9 - PubMed
  23. Gastroenterology. 1984 Jul;87(1):150-8 - PubMed
  24. Lab Invest. 1982 Apr;46(4):428-37 - PubMed
  25. Lancet. 1977 Aug 20;2(8034):367-9 - PubMed
  26. J Biol Chem. 1957 Jun;226(2):667-71 - PubMed
  27. Hepatology. 1991 Jul;14 (1):158-68 - PubMed
  28. J Lipid Res. 1983 Jun;24(6):701-20 - PubMed
  29. N Engl J Med. 1972 Jan 6;286(1):1-8 - PubMed
  30. Can J Physiol Pharmacol. 1988 Aug;66(8):1028-34 - PubMed
  31. J Lipid Res. 1978 Nov;19(8):945-55 - PubMed

Substances

MeSH terms

Publication Types

Grant support

LinkOut - more resources